Chimeric Antibody Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ( IgG, IgM, IgA, Others ); Applications ( Hospital, Scientific Research, Others )
Report Code: TIPRE00010926 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
A chimeric antibody (cAb) is an antibody made by fusing the antigen binding region (variable domains of the heavy and light chains, VH and VL) from one species like a mouse, with the constant domain (effector region) from another species such as a rabbit. After insertion of human and murine genes into a plasmid and transfection into bacteria, chimeric antibodies are produced as inclusion bodies. Following lysis of the cells, the chimeric antibodies are purified for in vivo use.
MARKET DYNAMICS
The chimeric antibody market is driving due to the growing prevalence of chronic diseases. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and development is driving the market growth.
MARKET SCOPE
The "Chimeric Antibody Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of chimeric antibody market with detailed market segmentation by type and, application. The chimeric antibody market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in chimeric antibody market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The chimeric antibody market is segmented on the basis of type and application. Based on type, the market is segmented as IgG, IgM, IgA and others. On the basis of application, the market is categorized as hospital, scientific research and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the chimeric antibody market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chimeric antibody market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting chimeric antibody market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chimeric antibody market in these regions.
The report covers key developments in the chimeric antibody market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chimeric antibody market are anticipated to have lucrative growth opportunities in the future with the rising demand for chimeric antibody in the global market. Below mentioned is the list of few companies engaged in the chimeric antibody market.
The report also includes the profiles of key players in chimeric antibody market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
A chimeric antibody (cAb) is an antibody made by fusing the antigen binding region (variable domains of the heavy and light chains, VH and VL) from one species like a mouse, with the constant domain (effector region) from another species such as a rabbit. After insertion of human and murine genes into a plasmid and transfection into bacteria, chimeric antibodies are produced as inclusion bodies. Following lysis of the cells, the chimeric antibodies are purified for in vivo use.
MARKET DYNAMICS
The chimeric antibody market is driving due to the growing prevalence of chronic diseases. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and development is driving the market growth.
MARKET SCOPE
The "Chimeric Antibody Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of chimeric antibody market with detailed market segmentation by type and, application. The chimeric antibody market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in chimeric antibody market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The chimeric antibody market is segmented on the basis of type and application. Based on type, the market is segmented as IgG, IgM, IgA and others. On the basis of application, the market is categorized as hospital, scientific research and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the chimeric antibody market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chimeric antibody market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting chimeric antibody market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chimeric antibody market in these regions.
The report covers key developments in the chimeric antibody market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chimeric antibody market are anticipated to have lucrative growth opportunities in the future with the rising demand for chimeric antibody in the global market. Below mentioned is the list of few companies engaged in the chimeric antibody market.
The report also includes the profiles of key players in chimeric antibody market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Aviva Systems Biology
- Biorbyt
- Biotem
- Creative-Biolabs
- EnCor Biotechnology Inc.
- ImmuQuest
- Jackson ImmunoResearch Laboratories
- MABTECH
- OmniAb Technology
- WILEX Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chimeric Antibody Market - By Type
1.3.2 Chimeric Antibody Market - By Applications
1.3.3 Chimeric Antibody Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHIMERIC ANTIBODY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHIMERIC ANTIBODY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHIMERIC ANTIBODY MARKET - GLOBAL MARKET ANALYSIS
6.1. CHIMERIC ANTIBODY - GLOBAL MARKET OVERVIEW
6.2. CHIMERIC ANTIBODY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CHIMERIC ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. IGG
7.3.1. Overview
7.3.2. IgG Market Forecast and Analysis
7.4. IGM
7.4.1. Overview
7.4.2. IgM Market Forecast and Analysis
7.5. IGA
7.5.1. Overview
7.5.2. IgA Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. CHIMERIC ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. SCIENTIFIC RESEARCH
8.4.1. Overview
8.4.2. Scientific Research Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CHIMERIC ANTIBODY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Chimeric Antibody Market Overview
9.1.2 North America Chimeric Antibody Market Forecasts and Analysis
9.1.3 North America Chimeric Antibody Market Forecasts and Analysis - By Type
9.1.4 North America Chimeric Antibody Market Forecasts and Analysis - By Applications
9.1.5 North America Chimeric Antibody Market Forecasts and Analysis - By Countries
9.1.5.1 United States Chimeric Antibody Market
9.1.5.1.1 United States Chimeric Antibody Market by Type
9.1.5.1.2 United States Chimeric Antibody Market by Applications
9.1.5.2 Canada Chimeric Antibody Market
9.1.5.2.1 Canada Chimeric Antibody Market by Type
9.1.5.2.2 Canada Chimeric Antibody Market by Applications
9.1.5.3 Mexico Chimeric Antibody Market
9.1.5.3.1 Mexico Chimeric Antibody Market by Type
9.1.5.3.2 Mexico Chimeric Antibody Market by Applications
9.2. EUROPE
9.2.1 Europe Chimeric Antibody Market Overview
9.2.2 Europe Chimeric Antibody Market Forecasts and Analysis
9.2.3 Europe Chimeric Antibody Market Forecasts and Analysis - By Type
9.2.4 Europe Chimeric Antibody Market Forecasts and Analysis - By Applications
9.2.5 Europe Chimeric Antibody Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Chimeric Antibody Market
9.2.5.1.1 Germany Chimeric Antibody Market by Type
9.2.5.1.2 Germany Chimeric Antibody Market by Applications
9.2.5.2 France Chimeric Antibody Market
9.2.5.2.1 France Chimeric Antibody Market by Type
9.2.5.2.2 France Chimeric Antibody Market by Applications
9.2.5.3 Italy Chimeric Antibody Market
9.2.5.3.1 Italy Chimeric Antibody Market by Type
9.2.5.3.2 Italy Chimeric Antibody Market by Applications
9.2.5.4 Spain Chimeric Antibody Market
9.2.5.4.1 Spain Chimeric Antibody Market by Type
9.2.5.4.2 Spain Chimeric Antibody Market by Applications
9.2.5.5 United Kingdom Chimeric Antibody Market
9.2.5.5.1 United Kingdom Chimeric Antibody Market by Type
9.2.5.5.2 United Kingdom Chimeric Antibody Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Chimeric Antibody Market Overview
9.3.2 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis
9.3.3 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Chimeric Antibody Market
9.3.5.1.1 Australia Chimeric Antibody Market by Type
9.3.5.1.2 Australia Chimeric Antibody Market by Applications
9.3.5.2 China Chimeric Antibody Market
9.3.5.2.1 China Chimeric Antibody Market by Type
9.3.5.2.2 China Chimeric Antibody Market by Applications
9.3.5.3 India Chimeric Antibody Market
9.3.5.3.1 India Chimeric Antibody Market by Type
9.3.5.3.2 India Chimeric Antibody Market by Applications
9.3.5.4 Japan Chimeric Antibody Market
9.3.5.4.1 Japan Chimeric Antibody Market by Type
9.3.5.4.2 Japan Chimeric Antibody Market by Applications
9.3.5.5 South Korea Chimeric Antibody Market
9.3.5.5.1 South Korea Chimeric Antibody Market by Type
9.3.5.5.2 South Korea Chimeric Antibody Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Chimeric Antibody Market Overview
9.4.2 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis
9.4.3 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Chimeric Antibody Market
9.4.5.1.1 South Africa Chimeric Antibody Market by Type
9.4.5.1.2 South Africa Chimeric Antibody Market by Applications
9.4.5.2 Saudi Arabia Chimeric Antibody Market
9.4.5.2.1 Saudi Arabia Chimeric Antibody Market by Type
9.4.5.2.2 Saudi Arabia Chimeric Antibody Market by Applications
9.4.5.3 U.A.E Chimeric Antibody Market
9.4.5.3.1 U.A.E Chimeric Antibody Market by Type
9.4.5.3.2 U.A.E Chimeric Antibody Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Chimeric Antibody Market Overview
9.5.2 South and Central America Chimeric Antibody Market Forecasts and Analysis
9.5.3 South and Central America Chimeric Antibody Market Forecasts and Analysis - By Type
9.5.4 South and Central America Chimeric Antibody Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Chimeric Antibody Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Chimeric Antibody Market
9.5.5.1.1 Brazil Chimeric Antibody Market by Type
9.5.5.1.2 Brazil Chimeric Antibody Market by Applications
9.5.5.2 Argentina Chimeric Antibody Market
9.5.5.2.1 Argentina Chimeric Antibody Market by Type
9.5.5.2.2 Argentina Chimeric Antibody Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHIMERIC ANTIBODY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHIMERIC ANTIBODY MARKET, KEY COMPANY PROFILES
12.1. AVIVA SYSTEMS BIOLOGY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIORBYT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOTEM
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CREATIVE-BIOLABS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ENCOR BIOTECHNOLOGY INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IMMUQUEST
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JACKSON IMMUNORESEARCH LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MABTECH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OMNIAB TECHNOLOGY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. WILEX INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chimeric Antibody Market - By Type
1.3.2 Chimeric Antibody Market - By Applications
1.3.3 Chimeric Antibody Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHIMERIC ANTIBODY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHIMERIC ANTIBODY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHIMERIC ANTIBODY MARKET - GLOBAL MARKET ANALYSIS
6.1. CHIMERIC ANTIBODY - GLOBAL MARKET OVERVIEW
6.2. CHIMERIC ANTIBODY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CHIMERIC ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. IGG
7.3.1. Overview
7.3.2. IgG Market Forecast and Analysis
7.4. IGM
7.4.1. Overview
7.4.2. IgM Market Forecast and Analysis
7.5. IGA
7.5.1. Overview
7.5.2. IgA Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. CHIMERIC ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. SCIENTIFIC RESEARCH
8.4.1. Overview
8.4.2. Scientific Research Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CHIMERIC ANTIBODY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Chimeric Antibody Market Overview
9.1.2 North America Chimeric Antibody Market Forecasts and Analysis
9.1.3 North America Chimeric Antibody Market Forecasts and Analysis - By Type
9.1.4 North America Chimeric Antibody Market Forecasts and Analysis - By Applications
9.1.5 North America Chimeric Antibody Market Forecasts and Analysis - By Countries
9.1.5.1 United States Chimeric Antibody Market
9.1.5.1.1 United States Chimeric Antibody Market by Type
9.1.5.1.2 United States Chimeric Antibody Market by Applications
9.1.5.2 Canada Chimeric Antibody Market
9.1.5.2.1 Canada Chimeric Antibody Market by Type
9.1.5.2.2 Canada Chimeric Antibody Market by Applications
9.1.5.3 Mexico Chimeric Antibody Market
9.1.5.3.1 Mexico Chimeric Antibody Market by Type
9.1.5.3.2 Mexico Chimeric Antibody Market by Applications
9.2. EUROPE
9.2.1 Europe Chimeric Antibody Market Overview
9.2.2 Europe Chimeric Antibody Market Forecasts and Analysis
9.2.3 Europe Chimeric Antibody Market Forecasts and Analysis - By Type
9.2.4 Europe Chimeric Antibody Market Forecasts and Analysis - By Applications
9.2.5 Europe Chimeric Antibody Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Chimeric Antibody Market
9.2.5.1.1 Germany Chimeric Antibody Market by Type
9.2.5.1.2 Germany Chimeric Antibody Market by Applications
9.2.5.2 France Chimeric Antibody Market
9.2.5.2.1 France Chimeric Antibody Market by Type
9.2.5.2.2 France Chimeric Antibody Market by Applications
9.2.5.3 Italy Chimeric Antibody Market
9.2.5.3.1 Italy Chimeric Antibody Market by Type
9.2.5.3.2 Italy Chimeric Antibody Market by Applications
9.2.5.4 Spain Chimeric Antibody Market
9.2.5.4.1 Spain Chimeric Antibody Market by Type
9.2.5.4.2 Spain Chimeric Antibody Market by Applications
9.2.5.5 United Kingdom Chimeric Antibody Market
9.2.5.5.1 United Kingdom Chimeric Antibody Market by Type
9.2.5.5.2 United Kingdom Chimeric Antibody Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Chimeric Antibody Market Overview
9.3.2 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis
9.3.3 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Chimeric Antibody Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Chimeric Antibody Market
9.3.5.1.1 Australia Chimeric Antibody Market by Type
9.3.5.1.2 Australia Chimeric Antibody Market by Applications
9.3.5.2 China Chimeric Antibody Market
9.3.5.2.1 China Chimeric Antibody Market by Type
9.3.5.2.2 China Chimeric Antibody Market by Applications
9.3.5.3 India Chimeric Antibody Market
9.3.5.3.1 India Chimeric Antibody Market by Type
9.3.5.3.2 India Chimeric Antibody Market by Applications
9.3.5.4 Japan Chimeric Antibody Market
9.3.5.4.1 Japan Chimeric Antibody Market by Type
9.3.5.4.2 Japan Chimeric Antibody Market by Applications
9.3.5.5 South Korea Chimeric Antibody Market
9.3.5.5.1 South Korea Chimeric Antibody Market by Type
9.3.5.5.2 South Korea Chimeric Antibody Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Chimeric Antibody Market Overview
9.4.2 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis
9.4.3 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Chimeric Antibody Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Chimeric Antibody Market
9.4.5.1.1 South Africa Chimeric Antibody Market by Type
9.4.5.1.2 South Africa Chimeric Antibody Market by Applications
9.4.5.2 Saudi Arabia Chimeric Antibody Market
9.4.5.2.1 Saudi Arabia Chimeric Antibody Market by Type
9.4.5.2.2 Saudi Arabia Chimeric Antibody Market by Applications
9.4.5.3 U.A.E Chimeric Antibody Market
9.4.5.3.1 U.A.E Chimeric Antibody Market by Type
9.4.5.3.2 U.A.E Chimeric Antibody Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Chimeric Antibody Market Overview
9.5.2 South and Central America Chimeric Antibody Market Forecasts and Analysis
9.5.3 South and Central America Chimeric Antibody Market Forecasts and Analysis - By Type
9.5.4 South and Central America Chimeric Antibody Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Chimeric Antibody Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Chimeric Antibody Market
9.5.5.1.1 Brazil Chimeric Antibody Market by Type
9.5.5.1.2 Brazil Chimeric Antibody Market by Applications
9.5.5.2 Argentina Chimeric Antibody Market
9.5.5.2.1 Argentina Chimeric Antibody Market by Type
9.5.5.2.2 Argentina Chimeric Antibody Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHIMERIC ANTIBODY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHIMERIC ANTIBODY MARKET, KEY COMPANY PROFILES
12.1. AVIVA SYSTEMS BIOLOGY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIORBYT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOTEM
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CREATIVE-BIOLABS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ENCOR BIOTECHNOLOGY INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IMMUQUEST
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JACKSON IMMUNORESEARCH LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MABTECH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OMNIAB TECHNOLOGY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. WILEX INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Aviva Systems Biology
2. Biorbyt
3. Biotem
4. Creative-Biolabs
5. EnCor Biotechnology Inc.
6. ImmuQuest
7. Jackson ImmunoResearch Laboratories
8. MABTECH
9. OmniAb Technology
10. WILEX Inc.
1. Aviva Systems Biology
2. Biorbyt
3. Biotem
4. Creative-Biolabs
5. EnCor Biotechnology Inc.
6. ImmuQuest
7. Jackson ImmunoResearch Laboratories
8. MABTECH
9. OmniAb Technology
10. WILEX Inc.